entertainment -WSS

entertainment

author：fashion 2025-10-02 11:10:20 - browse：5247

An interface with a wire frame human on the center left, a human brain on the top right, a microscope on the bottom left, and some codes on both sides — coverage from STAT — Adobe

If the past year was prelude, the U.S. government in 2024 is poised to re-write the rules surrounding the use of artificial intelligence in health care.

Just in the past few months, President Joe Biden ordered a sweeping crackdown on AI by federal health agencies; members of Congress promised to step up oversight and pass new legislation; and many AI experts, from within industry and outside of it, sounded alarms about the urgent need for standards.

The heightened scrutiny is driven by rapid advances of generative AI tools such as ChatGPT. But makers of all kinds of predictive models may, for the first time, be required to explain how their systems were developed and tested — and prove that they are safe, reliable, and fair.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Solving academic medical centers' existential crisis

WSS

Second House panel advances two

Wearables generate powerful data but its not useful to doctors, yet

The explosion of genetic testing requires a new approach

2023 STAT Wunderkinds: get to know the winners

STAT Summit: Biotech founders on deal

Beam Therapeutics to lay off 20% of its staff, re

entertainment

entertainment

focus

ChatGPT in medicine: STAT answers readers' burning questions

Studies point to risks of excluding people with obesity from drug trials

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Glen Campbell's doctor discusses his public struggle with Alzheimer's

ChatGPT in medicine: STAT answers readers' burning questions

When prostate cancer spreads, where it goes matters

Medical leaders decry Supreme Court decision on affirmative action

With measles on the rise, a personal story of a devastating disease

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

focus

Military medical care influenced by rank and race, new study finds

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Venture capitalist Bob Kocher on the state of digital health

STAT Readout Newsletter: Today's biggest biotech updates

Hospital price transparency does save money, advocate argues

HIV vaccine remains elusive. Immunologists keep trying new ideas

focus

leisure time

focus

explore